Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Magda Negrão"'
Autor:
Marta Martins, Luís Costa, Rita Fior, André Mansinho, Ana Lucia-Costa, Catarina Abreu, Teresa R. Pacheco, Maria J. Brito, Helder Mansinho, Ana R. Miranda, Miguel Godinho Ferreira, Ana T. Xavier, José Vílchez, João Gramaça, Daniel Machado, Lina M. Gallego-Paez, Daniel Sobral, Paula Borralho, Afonso Fernandes, Magda Negrão, Cátia Rebelo de Almeida, Raquel Cruz-Duarte
Purpose:Cetuximab is an EGFR-targeted therapy approved for the treatment of RAS wild-type (WT) metastatic colorectal cancer (mCRC). However, about 60% of these patients show innate resistance to cetuximab. To increase cetuximab efficacy, it is crucia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61d133d617637977ca820648022af1b8
https://doi.org/10.1158/1078-0432.c.6531303.v1
https://doi.org/10.1158/1078-0432.c.6531303.v1
Autor:
Marta Martins, Luís Costa, Rita Fior, André Mansinho, Ana Lucia-Costa, Catarina Abreu, Teresa R. Pacheco, Maria J. Brito, Helder Mansinho, Ana R. Miranda, Miguel Godinho Ferreira, Ana T. Xavier, José Vílchez, João Gramaça, Daniel Machado, Lina M. Gallego-Paez, Daniel Sobral, Paula Borralho, Afonso Fernandes, Magda Negrão, Cátia Rebelo de Almeida, Raquel Cruz-Duarte
Supplementary Figure from Predictive and Therapeutic Implications of a Novel PLCγ1/SHP2-Driven Mechanism of Cetuximab Resistance in Metastatic Colorectal Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::083ae1169e4cc776a94303306d7877c5
https://doi.org/10.1158/1078-0432.22484019
https://doi.org/10.1158/1078-0432.22484019
Autor:
Marta Martins, Luís Costa, Rita Fior, André Mansinho, Ana Lucia-Costa, Catarina Abreu, Teresa R. Pacheco, Maria J. Brito, Helder Mansinho, Ana R. Miranda, Miguel Godinho Ferreira, Ana T. Xavier, José Vílchez, João Gramaça, Daniel Machado, Lina M. Gallego-Paez, Daniel Sobral, Paula Borralho, Afonso Fernandes, Magda Negrão, Cátia Rebelo de Almeida, Raquel Cruz-Duarte
Supplementary Data from Predictive and Therapeutic Implications of a Novel PLCγ1/SHP2-Driven Mechanism of Cetuximab Resistance in Metastatic Colorectal Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cbf57725dac3cb782017ff755cd50cad
https://doi.org/10.1158/1078-0432.22484034
https://doi.org/10.1158/1078-0432.22484034
Autor:
Raquel Cruz-Duarte, Cátia Rebelo de Almeida, Magda Negrão, Afonso Fernandes, Paula Borralho, Daniel Sobral, Lina M. Gallego-Paez, Daniel Machado, João Gramaça, José Vílchez, Ana T. Xavier, Miguel Godinho Ferreira, Ana R. Miranda, Helder Mansinho, Maria J. Brito, Teresa R. Pacheco, Catarina Abreu, Ana Lucia-Costa, André Mansinho, Rita Fior, Luís Costa, Marta Martins
Publikováno v:
Clinical Cancer Research
Clinical Cancer Research, American Association for Cancer Research, 2022, pp.clincanres.1992.2021. ⟨10.1158/1078-0432.CCR-21-1992⟩
Clinical Cancer Research, American Association for Cancer Research, 2022, pp.clincanres.1992.2021. ⟨10.1158/1078-0432.CCR-21-1992⟩
© 2022 The Authors; Published by the American Association for Cancer Research. This open access article is distributed under Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 International (CC BY-NC-ND)
Purpose: Cetuximab is
Purpose: Cetuximab is
Autor:
Pierre Bedossa, Magda Negrão, Jerome Raffenne, Jérôme Cros, Miguel Godinho Ferreira, Rita Fior, Nicolas Poté, Samira Laouirem, Valérie Paradis, Slimane Ait Si Ali, Miguel Albuquerque
Publikováno v:
Liver International
Liver International, 2020, 40, Epub ahead of print. ⟨10.1111/LIV.14381⟩
Liver International, Wiley-Blackwell, 2020, 40 (4), pp.956-967. ⟨10.1111/liv.14381⟩
Liver International, Wiley-Blackwell, 2020, 40, Epub ahead of print. ⟨10.1111/LIV.14381⟩
Liver International, 2020, 40, Epub ahead of print. ⟨10.1111/LIV.14381⟩
Liver International, Wiley-Blackwell, 2020, 40 (4), pp.956-967. ⟨10.1111/liv.14381⟩
Liver International, Wiley-Blackwell, 2020, 40, Epub ahead of print. ⟨10.1111/LIV.14381⟩
International audience; BACKGROUND & AIMS:Vascular invasion is a major prognostic factor in hepatocellular carcinoma (HCC). We previously identified histone H4 acetylated at lysine 16 (H4K16ac), a histone modification involved in transcription activa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49e294b1b9bdb0059bfff5011fe1fc0f
https://www.hal.inserm.fr/inserm-02532680
https://www.hal.inserm.fr/inserm-02532680
Autor:
Gonçalo Bernardes, Rita Fior, Miguel Godinho Ferreira, Magda Negrão, João Conde, Bruno Oliveira, Benjamin Stenton
Creating ways to control drug activation at specific tissues while sparing healthy tissues remains a major challenge. The administration of exogenous triggers offers the possibility for precise and traceless drug activation. However, ensuring localiz
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::33773ebd89883d9de52c3cb18ebeebfa
https://doi.org/10.26434/chemrxiv.7327904
https://doi.org/10.26434/chemrxiv.7327904
Autor:
João Conde, Rita Fior, Gonçalo J. L. Bernardes, Felipe S. S. Schneider, Magda Negrão, Bruno L. Oliveira, Josiel B. Domingos, Giovanni F. Caramori, Cátia Rebelo de Almeida, Carlos Cordeiro, Benjamin J Stenton, V B Unnikrishnan, Miguel Godinho Ferreira
Publikováno v:
Journal of the American Chemical Society
Journal of the American Chemical Society, American Chemical Society, 2020, 142 (24), pp.10869-10880. ⟨10.1021/JACS.0C01622⟩
Journal of the American Chemical Society, 2020, 142 (24), pp.10869-10880. ⟨10.1021/JACS.0C01622⟩
Journal of the American Chemical Society, American Chemical Society, 2020, 142 (24), pp.10869-10880. ⟨10.1021/JACS.0C01622⟩
Journal of the American Chemical Society, 2020, 142 (24), pp.10869-10880. ⟨10.1021/JACS.0C01622⟩
International audience; The ability to create ways to control drug activation at specific tissues while sparing healthy tissues remains a major challenge. The administration of exogenous target-specific triggers offers the potential for traceless rel